$18.28
0.593.34%
Last update: Nov 6, 4:00 PM
Arcus Biosciences Inc
RCUSNYSE
The average analyst price target for Arcus Biosciences is $37.29, 104.0% above the current price. Of 14 analysts, 13 rate it Buy and 1 Hold. Targets range from $14 to $50. The latest change came on Nov 5, 2026, when Leerink Partners raised its price target on Arcus Biosciences from $46 to $49 and kept an Outperform rating.
Price Target Range — 13 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months
